Related Experiment Videos
Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery
C Biron-Andréani1, G Dupeyron, M Mainemer
1Laboratory of Haematology, University Hospital Montpellier-Nîmes, Montpellier, France.
A 40-year-old patient with severe haemophilia A and an inhibitor against factor VIII underwent a cataract extraction under local anaesthesia. Recombinant activated factor VII was use to achieve haemostasis. The procedure was successful. Neither bleeding complications nor side effects occurred.
A 40-year-old patient with severe haemophilia A and an inhibitor against factor VIII underwent a cataract extraction under local anaesthesia. Recombinant activated factor VII was use to achieve haemostasis. The procedure was successful. Neither bleeding complications nor side effects occurred.